Company Filing History:
Years Active: 2018-2023
Title: Kristen A. Batich: Innovating Cancer Immunotherapy
Introduction
Kristen A. Batich, based in Durham, North Carolina, is an accomplished inventor renowned for her groundbreaking contributions to cancer immunotherapy. With a total of three patents, her innovative research focuses on enhancing the efficacy of dendritic cell vaccines, aiming to improve treatment outcomes for cancer patients.
Latest Patents
Her latest patent, titled "Tetanus toxoid and CCL3 improve DC vaccines," outlines a significant advancement in the realm of immunotherapy. By pre-conditioning vaccine sites with potent recall antigens, such as tetanus/diphtheria (Td) toxoid, the study demonstrates enhanced lymph node homing and the efficacy of tumor antigen-specific dendritic cell (DC) vaccines. Notably, patients receiving Td experienced improved bilateral DC migration and significantly increased survival rates. In murine studies, this approach further demonstrated the ability to enhance DC migration and suppress tumor growth through a dependency on chemokines such as CCL3 and CCL21, as well as Td-activated CD4+ T cells. The research highlights the potential of employing recall antigens as a viable strategy to bolster DC homing to lymph nodes, ultimately enhancing antitumor immunotherapy effectiveness.
Career Highlights
Kristen A. Batich is affiliated with Duke University, where she continues to push the boundaries of cancer research and immunotherapy. Her dedication to advancing medical science is reflected in her innovative work, which has garnered attention and respect within the academic and medical communities.
Collaborations
Throughout her career, Kristen has collaborated with notable colleagues, including John Howard Sampson and Duane A. Mitchell. Together, they contribute to the collective knowledge and innovation within the field of immunotherapy, advancing research that holds promise for future treatments.
Conclusion
Kristen A. Batich stands out as a pioneering inventor making significant strides in the battle against cancer. Her patents and collaborative efforts at Duke University underline her commitment to improving patient outcomes through innovative immunotherapy strategies. As cancer research continues to evolve, the contributions of dedicated inventors like Kristen will undoubtedly play a crucial role in shaping the future of medicine.